KPWS
RVMD icon

Kestra Private Wealth Services’s Revolution Medicines RVMD Stock Holding History

Kestra Private Wealth Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
+1,982
New +$290K ﹤0.01% 1405
2025
Q2 		– Sell
-6,117
Closed -$216K – 1666
2025
Q1 		$216K Buy
+6,117
New +$248K ﹤0.01% 1356

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Kestra Private Wealth Services's RVMD Position: Q2 2026 in Review

Kestra Private Wealth Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,982 shares worth $371K. The stake represents ﹤0.01% of the portfolio and ranks #1405 among its holdings. This is a return to the name: Kestra Private Wealth Services previously reported a position in RVMD as recently as Q1 2025.

Kestra Private Wealth Services first reported a position in RVMD in Q1 2025 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Kestra Private Wealth Services held 1,982 shares of Revolution Medicines worth $371K as of Q2 2026.
  • Revolution Medicines was a new Kestra Private Wealth Services position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1405 holding.
  • Kestra Private Wealth Services first reported a position in Revolution Medicines in Q1 2025 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.